- Home
- KRMD vs BMN Comparison
KRMD vs BMN Comparison
Compare KRMD & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- BMN
- Stock Information
- Founded
- KRMD 1980
- BMN 2020
- Country
- KRMD United States
- BMN United States
- Employees
- KRMD N/A
- BMN 19800
- Industry
- KRMD Medical/Dental Instruments
- BMN Trusts Except Educational Religious and Charitable
- Sector
- KRMD Health Care
- BMN Finance
- Exchange
- KRMD Nasdaq
- BMN Nasdaq
- Market Cap
- KRMD 192.3M
- BMN 153.9M
- IPO Year
- KRMD N/A
- BMN N/A
- Fundamental
- Price
- KRMD $3.98
- BMN $24.71
- Analyst Decision
- KRMD Strong Buy
- BMN
- Analyst Count
- KRMD 4
- BMN 0
- Target Price
- KRMD $4.63
- BMN N/A
- AVG Volume (30 Days)
- KRMD 76.9K
- BMN 29.9K
- Earning Date
- KRMD 11-12-2025
- BMN 01-01-0001
- Dividend Yield
- KRMD N/A
- BMN 4.66%
- EPS Growth
- KRMD N/A
- BMN N/A
- EPS
- KRMD N/A
- BMN N/A
- Revenue
- KRMD $36,848,451.00
- BMN N/A
- Revenue This Year
- KRMD $21.08
- BMN N/A
- Revenue Next Year
- KRMD $16.37
- BMN N/A
- P/E Ratio
- KRMD N/A
- BMN N/A
- Revenue Growth
- KRMD 19.57
- BMN N/A
- 52 Week Low
- KRMD $1.86
- BMN $21.51
- 52 Week High
- KRMD $5.05
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- KRMD 45.19
- BMN 43.84
- Support Level
- KRMD $3.94
- BMN $24.71
- Resistance Level
- KRMD $4.32
- BMN $25.08
- Average True Range (ATR)
- KRMD 0.16
- BMN 0.22
- MACD
- KRMD -0.02
- BMN -0.04
- Stochastic Oscillator
- KRMD 12.34
- BMN 32.39
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.